WETG - WeTrade Group shares surge after iniking monkeypox test kit partnership

• WeTrade Group ( NASDAQ: WETG ) stock touched an all-time high of $50.50 in early Friday trading, more than double its previous close of $18.30, after announcing a partnership with Jiqing Bio to exclusively sell monkypox test kits and antigen tests. At 2:15 PM ET, the stock is up ~15% at $21.
• The two companies plan to produce and provide exclusive sales channels for monkeypox virust test kits and antigen kits worldwide. The partnership also brings WeTrade ( WETG ) into the medical industry.
• WeTrade ( WETG ) describes itself as a technical service provider of software-as-a-service and cloud intelligent system for micro-businesses with its YCloud for marketing, profit management, payment, and supply chain systems.
• The company uplisted to Nasdaq in an initial public offering in July.

For further details see: